Diseases_MDPI Share the #SystematicReview by Henrique Villa Chagas, et al.
Can DPP-4 #Inhibitors Improve #Glycemic Control and Preserve Beta-Cell Function in Type 1 #Diabetes Mellitus? A Systematic Review
mdpi.com/2079-9721/14/1/28
1
34
A new smart coating from University of Queensland researchers uses #nanocontainers to release rust #inhibitors only when damage occurs, helping slow corrosion and extend protection. 🧐
mou.sr/4y2MYFV
ALT Blue-gloved hand holding two small square metal samples side by side—one clean and shiny, the other heavily rusted—demonstrating an anti-corrosion comparison.
3
657
🎥 Missed the EHC #ERIN Webinar on #HaemophiliaB with #Inhibitors? The recording is now available — watch the conversation between clinicians & patient advocates, organised in collaboration with @EAHADnews👇️ piped.video/KG3dpFR5V4c?si=FfM_…
3
3
287
🩸 Register now! Join our #ERIN Webinar on #HaemophiliaB with #Inhibitors – From Daily Challenges to Clinical Management 📅 3 July 2026 | 18:00 CEST 🌐 EN + RU translation 🤝 In collaboration with @EAHADnews
community.ehc.eu/event/erin-…
2
3
147
🩸 Registration is open! Join the #ERIN Webinar on #HaemophiliaB with #Inhibitors – From Daily Challenges to Clinical Management 📅 3 July 2026 | 18:00-19:00 CEST | Online 🌐 EN + RU translation 👉 Register: buff.ly/GVy9rwn
3
3
347
Is the benefit of #PCSK9 #inhibitors driven by the #drug itself—or by baseline #LDL-C and patient risk? Prof.
@SABOURETCardio
and team explore key insights from ODYSSEY OUTCOMES vs FOURIER and clinical implications.
imrpress.com/journal/RCM/27/…
#Cardiovascular #Atherosclerosis
1
2
741
A rapid point-of-care test for diagnosis of factor VIII #inhibitors in haemophilia A patients - Journal of Thrombosis and Haemostasis jthjournal.org/article/S1538…
1
6
702
🔬MedChemExpress：世界中の研究を支援
包括的なポートフォリオで発見を加速：
・ #Inhibitors ＆ #Agonists：20以上のシグナル経路にわたり、1,500以上の標的タンパク質に対応する150,000以上の化合物
・組換え #Proteins：14,000以上の高品質タンパク質
・ #Antibodies：10,000以上の高品質抗体
・ #ADCs：2,000以上の抗体薬物複合体
・ #PROTACs ＆ モレキュラーグルー：標的タンパク質分解のための5,000以上の分子
・ #Oligonucleotides：50,000以上の配列
・ #FluorescentDyes：イメージングおよびアッセイ用の5,000以上
・ #Organoids：高度な疾患モデリング向け100以上の製品
📚がん、神経科学、炎症、代謝、幹細胞など、400以上の疾患・研究分野に対応
📊150,000以上の溶解度測定データ、臨床トラッキングおよび承認データによりサポート
🌎13,000以上の主要製薬企業および学術機関と連携し、MedChemExpressは信頼されるサイエンスパートナーとして、世界中の数百万人の研究者を支援しています。
#ライフサイエンス #創薬 #バイオテクノロジー #がん研究 #神経科学 #免疫学 #代謝疾患
🔬MedChemExpress: Empowering Research Worldwide
Accelerating discoveries with a comprehensive portfolio:
• #Inhibitors & #Agonists: 150,000+ compounds targeting 1,500+ proteins across 20+ pathways
• Recombinant #Proteins: 14,000+ high-quality proteins
• #Antibodies: 10,000+ high-quality antibodies
• #ADCs: 2,000+ Antibody-Drug Conjugates
• #PROTACs & Molecular Glues: 5,000+ molecules for targeted protein degradation
• #Oligonucleotides: 50,000+ sequences
• #FluorescentDyes: 5,000+ for imaging and assays
• #Organoids: 100+ products for advanced disease modeling
📚Over 400 disease/field studies spanning cancer, neurology, inflammation, metabolism, stem cells, and more
📊Supported by 150,000+ solubility measurements, clinical tracking, and approval data
🌎Collaborating with 13,000+ leading pharma and academic institutions, MedChemExpress supports millions of researchers worldwide as a trusted partner in science.
#LifeScience #DrugDiscovery #Biotech #CancerResearch #Neurology #Immunology #MetabolicDiseases
4
93
🔬MedChemExpress: Empowering Research Worldwide
Accelerating discoveries with a comprehensive portfolio:
• #Inhibitors & #Agonists: 150,000+ compounds targeting 1,500+ proteins across 20+ pathways
• Recombinant #Proteins: 14,000+ high-quality proteins
• #Antibodies: 10,000+ high-quality antibodies
• #ADCs: 2,000+ Antibody-Drug Conjugates
• #PROTACs & Molecular Glues: 5,000+ molecules for targeted protein degradation
• #Oligonucleotides: 50,000+ sequences
• #FluorescentDyes: 5,000+ for imaging and assays
• #Organoids: 100+ products for advanced disease modeling
📚Over 400 disease/field studies spanning cancer, neurology, inflammation, metabolism, stem cells, and more
📊Supported by 150,000+ solubility measurements, clinical tracking, and approval data
🌎Collaborating with 13,000+ leading pharma and academic institutions, MedChemExpress supports millions of researchers worldwide as a trusted partner in science.
#LifeScience #DrugDiscovery #Biotech #CancerResearch #Neurology #Immunology #MetabolicDiseases
5
9
202
#Genomic ancestry, F8 variants, and #immune tolerance in hemophilia A patients with #inhibitors: exome sequencing insights. No association has been found in Brazilian population haematologica.org/article/vi…
1
3
248
📖A new therapeutic era for hypertrophic #cardiomyopathy?
Prof. Farbod Sedaghat-Hamedani (@UniHeidelberg) summarizes the mechanistic and clinical evidence behind cardiac myosin #inhibitors in HCM.
imrpress.com/journal/RCM/27/…
#Cardiology #CardioTwitter #HeartFailure
5
886
Article✍️Discovery of #peptidomimetic #inhibitors of #CREB/#CBP by targeting #hydrophobic #grooves on the surface of the #CBP #KIX #domain. From Dr. Cai @USouthFlorida; Dr. Xiao @UNTHealth_TCOM; Dr. Tran @MoffittNews; @USFHealthMed;
sciencedirect.com/science/ar….
2
87
In #utero exposure to #TNF #inhibitors among #offspring born to mothers with chronic inflammatory diseases was not associated with an increased risk for serious infections. medscape.com/viewarticle/tnf…
ALT In utero exposure to TNF inhibitors among offspring born to mothers with chronic inflammatory diseases was not associated with an increased risk for serious infections.
3
2
83
Efficacy and safety of #DPP-1 #inhibitors in #bronchiectasis: a GRADE-assessed meta-analysis of randomized controlled trials. Open Access. interasma.org/2025/11/27/eff…
1
5
6
601
📚 Plant #OrganicAcids as Natural #Inhibitors of #FoodbornePathogens
🔗 mdpi.com/2076-3417/14/14/634…
👨🔬 by Tomasz M. Karpinski and Marcin Ożarowski
🏫 @PUMS_tweets / Institute of Natural Fibres and Medicinal Plants—National Research Institute
#antimicrobials #antiseptics #naturalcompounds
1
4
38
Pin1 #Inhibitors show potential to block HSV-1 replication by reinforcing the nuclear membrane, preventing the #Virus from escaping infected cells and reducing cold sore outbreaks. @Hiroshima_Univ doi.org/g967f9 medicalxpress.com/news/2025-…
10
40
32,794
We began the second day of #EHC2025 by discussing rare bleeding disorders with an in-depth analysis of #fibrinogen defects, #inhibitors, and #BDUC.
@EHC_Haemophilia
1
3
86
Dominik Ćepić is providing us with insight into how the life of a person with #HaemophiliaB and #inhibitors looks. "I am here to be an advocate for things to change!" 📣 #EHC2025
1
2
4
136
Day 2 of the #EHC2025 opens with a deep dive into #FibrinogenDefects, #inhibitors & #BDUC.
A. Casini, D. Ćepić & J. Gebhart, moderated by M.E. Mancuso & J. O’Leary, shared valuable insights on the complexities of extremely rare bleeding disorders.
1
1
3
174
😊🎉Super excited to see our collab work on #inflammation #inhibitors led by Rajendra Karki @SeoulNatlUni & Chirag Patel @TIIuae being featured on the #cover of #Cell Chem Biol @CellChemBiol & highlighted at #Nature Reviews Drug Discovery @NatRevDrugDisc 1/2 @JCSMR @ourANU
ALT NLRP3 inhibitors featured in Cell Chemical Biology and Nature Reviews Drug Discovery, Sep 2025
2
3
16
662